Celgene gave Evotec a $5 million milestone payment from a 10-month-old collaboration to study neurodegenerative diseases. The payment was related to the successful completion of a screening campaign using an induced pluripotent stem cell-based screening platform from Evotec.
Evotic gains $5M in neurodegenerative diseases deal with Celgene
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.